Ambeed.cn

首页 / / / FGFR / Ferulic Acid/阿魏酸

Ferulic Acid/阿魏酸 {[allProObj[0].p_purity_real_show]}

货号:A137025 同义名: 3-甲氧基-4-羟基苯基丙烯酸 / Coniferic acid; 4-hydroxy-3-Methoxycinnamic Acid

Ferulic Acid是一种天然存在的酚类植物化学物,存在于植物细胞壁中,具有抗氧化作用。

Ferulic Acid/阿魏酸 化学结构 CAS号:1135-24-6
Ferulic Acid/阿魏酸 化学结构
CAS号:1135-24-6
Ferulic Acid/阿魏酸 3D分子结构
CAS号:1135-24-6
Ferulic Acid/阿魏酸 化学结构 CAS号:1135-24-6
Ferulic Acid/阿魏酸 3D分子结构 CAS号:1135-24-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Ferulic Acid/阿魏酸 纯度/质量文件 产品仅供科研

货号:A137025 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 FGFR FGFR1 FGFR2 FGFR3 FGFR4 其他靶点 纯度
Tyrphostin AG1296 +

FGFR (Swiss 3T3), IC50: 12.3 μM

PDGFR 99%+
Pazopanib +

FGFR, IC50: 140 nM

99%
Erdafitinib RET 99%+
Gambogenic acid 98+%
Sulfatinib +++

FGFR1, IC50: 15 nM

99+%
Nintedanib esylate +

FGFR1, IC50: 69 nM

++

FGFR2, IC50: 37 nM

+

FGFR3, IC50: 108 nM

98%
Zoligratinib +++

FGFR1, IC50: 9.3 nM

+++

FGFR2, IC50: 7.6 nM

++

FGFR3, IC50: 22 nM

+

FGFR4, IC50: 290 nM

99%+
MK-2461 +

FGFR1, IC50: 65 nM

++

FGFR2, IC50: 39 nM

++

FGFR3, IC50: 50 nM

98%+
SU 5402 ++

FGFR1, IC50: 30 nM

98%
Brivanib +

FGFR1, IC50: 148 nM

99%+
Lucitanib ++

FGFR1, IC50: 17.5 nM

+

FGFR2, IC50: 82.5 nM

99%+
Ponatinib ++++

FGFR1, IC50: 2.2 nM

98%
PD-166866 +

FGFR1, IC50: 52.4 nM

99%
Narazaciclib ++

FGFR1, IC50: 26 nM

RET 99%+
Lactate +++

FGFR1, IC50: 8 nM

+++

FGFR3, IC50: 9 nM

c-Kit,FLT3 85%
Lenvatinib mesylate ++

FGFR1, IC50: 46 nM

c-RET 99%
LY2874455 ++++

FGFR1, IC50: 2.8 nM

++++

FGFR2, IC50: 2.6 nM

+++

FGFR3, IC50: 6.4 nM

+++

FGFR4, IC50: 6 nM

99%+
FIIN-2 +++

FGFR1, IC50: 3.09 nM

+++

FGFR2, IC50: 4.3 nM

++

FGFR3, IC50: 27 nM

++

FGFR4, IC50: 45.3 nM

99%
FIIN-3 +++

FGFR1, IC50: 13.1 nM

++

FGFR2, IC50: 21 nM

++

FGFR3, IC50: 31.4 nM

++

FGFR4, IC50: 35.3 nM

98%
Infigratinib ++++

FGFR1, IC50: 0.9 nM

++++

FGFR2, IC50: 1.4 nM

++++

FGFR3 (K650E), IC50: 4.9 nM

FGFR3, IC50: 1.0 nM

+

FGFR4, IC50: 60 nM

99%+
Danusertib ++

FGFR1, IC50: 47 nM

RET 99%+
R1530 ++

FGFR1, IC50: 28 nM

98%
ENMD-2076 +

FGFR1, IC50: 92.7 nM

+

FGFR2, IC50: 70.8 nM

RET,FLT3 98%
Dovitinib +++

FGFR1, IC50: 8 nM

+++

FGFR3, IC50: 9 nM

c-Kit,FLT3 99%+
Sorafenib +

FGFR1, IC50: 580 nM

99%
SSR128129E +

FGFR1, IC50: 1.9 μM

99%+
AZD-4547 ++++

FGFR1, IC50: 0.2 nM

++++

FGFR2, IC50: 2.5 nM

++++

FGFR3, IC50: 1.8 nM

98%
Lenvatinib ++

FGFR1, IC50: 46 nM

RET 98%
PD173074 ++

FGFR1, IC50: ~25 nM

99%+
S49076 ++

FGFR1, IC50: 18 nM

+++

FGFR2, IC50: 17 nM

+++

FGFR3, IC50: 15 nM

98%
Futibatinib ++++

FGFR1, IC50: 1.8 nM

++++

FGFR2, IC50: 1.4 nM

++++

FGFR3, IC50: 1.6 nM

+++

FGFR4, IC50: 3.7 nM

99%+
Ferulic Acid +

FGFR1, IC50: 3.78 μM

+

FGFR2, IC50: 12.5 μM

98%
Nintedanib +

FGFR1, IC50: 69 nM

++

FGFR2, IC50: 37 nM

+

FGFR3, IC50: 108 nM

+

FGFR4, IC50: 610 nM

99+%
ASP5878 ++++

FGFR1, IC50: 0.47 nM

++++

FGFR2, IC50: 0.6 nM

++++

FGFR3, IC50: 0.74 nM

+++

FGFR4, IC50: 3.5 nM

99%
PRN1371 ++++

FGFR1, IC50: 0.6 nM

++++

FGFR2, IC50: 1.3 nM

+++

FGFR3, IC50: 4.1 nM

++

FGFR4, IC50: 19.3 nM

99%
Derazantinib +++

FGFR1, IC50: 4.5 nM

++++

FGFR2, IC50: 1.8 nM

+++

FGFR3, IC50: 4.5 nM

++

FGFR4, IC50: 34 nM

RET 99%+
ODM-203 +++

FGFR1, IC50: 11 nM

+++

FGFR2, IC50: 16 nM

+++

FGFR3, IC50: 6 nM

++

FGFR4, IC50: 35 nM

99%+
Pemigatinib ++++

FGFR1, IC50: 0.4 nM

++++

FGFR2, IC50: 0.5 nM

++++

FGFR3, IC50: 1.2 nM

++

FGFR4, IC50: 30 nM

99%+
SKLB 610 PDGFR 99%+
Alofanib 99%+
Lirafugratinib 99%
Masitinib mesylate FAK 99%+
BLU9931 +

FGFR3, IC50: 150 nM

+++

FGFR4, IC50: 3 nM

99%+
BO-264 99%+
Fisogatinib +++

FGFR4, IC50: 5 nM

99%+
H3B-6527 ++++

FGFR4, IC50: <1.2 nM

99%+
Roblitinib ++++

FGFR4, IC50: 1.9 nM

99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Ferulic Acid/阿魏酸 生物活性

靶点
  • FGFR2

    FGFR2, IC50:12.5 μM

  • FGFR1

    FGFR1, IC50:3.78 μM

描述 Ferulic Acid, a kind of phenolic compound isolated from Tetragonia tetragonioides, has many biological activities. In vitro studies, ferulic acid has whitening effect on the B16F10 mouse melanoma cell line and anti-wrinkle activity on the CCD-986sk human dermal fibroblast cell line, while shows no cytotoxicity at concentrations up to 20 μM[1]. Besides this, it was found that ferulic acid could effectively inhibit the epidermal growth factor receptor (EGFR) in human breast cancer cells, through down-regulating the Tyr 1068 autophosphorylation[2]. In vivo studies, ferulic acid has the ability of ameliorating the diabetes-induced cognition lesions in rat via the regulation of protein tyrosine phosphatase 1B (PTP1B) and insulin signaling pathway[3]. In addition, ferulic acid could contribute to the reversal of inflammatory response induced by chronic unpredictable mild stress (CUMS) in mice[4].

Ferulic Acid/阿魏酸 细胞实验

Cell Line
Concentration Treated Time Description References
J774A.1 cells 12.5-100 µg/ml 2 h To investigate the inhibitory effect of ferulic acid on NLRP3 inflammasome-mediated canonical pyroptosis, results showed that ferulic acid significantly inhibited the release of LDH and IL-1β MedComm (2020). 2023 Apr 20;4(3):e255.
RAW264.7 cells 50 µg/ml 2 h To investigate the inhibitory effect of ferulic acid on caspase-11 inflammasome-mediated non-canonical pyroptosis, results showed that ferulic acid significantly reduced LDH release and PI uptake MedComm (2020). 2023 Apr 20;4(3):e255.
BMDMs 50 µg/ml 2 h To investigate the inhibitory effect of ferulic acid on caspase-11 inflammasome-mediated non-canonical pyroptosis, results showed that ferulic acid significantly reduced LDH release and IL-1β secretion MedComm (2020). 2023 Apr 20;4(3):e255.
Caco-2 cells 0-500 µM 24 h To assess the dose-dependent toxicity of FA in vitro, cell viabilities were determined on Caco-2 using a WST assay. Up to 500 µM FA, cell survival was 100% for 24 h, while 1250 µM FA significantly reduced cell viability. Antioxidants (Basel). 2022 Jul 26;11(8):1448.
Hippocampal Neurons 5 and 10 µM 2 h FA preincubation prevented the Aβ-induced loss of synaptic proteins, including GluN2B, PSD-95, and synapsin1 Neurotherapeutics. 2023 Jul;20(4):1081-1108.
BV2 microglial cells 0.5 mg/ml 18 h To evaluate the regulatory effect of Ferulic Acid on BV2 microglial cell polarization under hypoxia, the results showed that Ferulic Acid significantly reduced the number of iNOS+ cells and increased the number of Arg1+ cells, indicating that Ferulic Acid can shift microglial polarization from M1 to M2 phenotype. Front Immunol. 2022 Sep 2;13:976729.
Human retinal endothelial cells (HRECs) 0.5 mg/ml 16 h To evaluate the effect of Ferulic Acid-treated microglial supernatants on HRECs tube formation and migration, the results showed that Ferulic Acid-treated microglial supernatants significantly inhibited HRECs tube formation and migration. Front Immunol. 2022 Sep 2;13:976729.
Skeletal Stem Cells (SSCs) 30 μM 24 h Ferulic acid significantly rescued the radiation-induced impairment of SSCs by restoring their proliferation, osteogenic differentiation, and self-renewal capacity, and by activating the p38/MAPK and ERK/MAPK pathways. Stem Cells Transl Med. 2021 Aug;10(8):1217-1231.
Mouse tracheal epithelial cells (MTECs) 0, 25, 50, 100, 200, 400, 800 μM 24 h To evaluate the effect of Ferulic Acid on the viability of MTECs, results showed that 25-200 μM Ferulic Acid significantly increased cell viability, while 400-800 μM began to show toxic effects. Respir Res. 2021 Dec 4;22(1):308.
Mouse tracheal epithelial cells (MTECs) 200 μM 24 h To evaluate the effect of Ferulic Acid on ENaC activity in LPS-induced MTECs, results showed that Ferulic Acid reversed the LPS-induced reduction of ENaC activity. Respir Res. 2021 Dec 4;22(1):308.

Ferulic Acid/阿魏酸 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Rats Insomnia model Oral 40 mg/kg Single dose The pharmacokinetics and tissue distribution of FA-SMEDDS were evaluated. The results showed that FA-SMEDDS significantly improved the oral bioavailability of FA, reduced its distribution in the kidney, and increased its distribution in the brain. Int J Nanomedicine. 2020 Mar 25;15:2059-2070
C57BL/6 mice LPS-induced sepsis model Intraperitoneal injection 50 mg/kg Single injection, lasting 6 hours To investigate the protective effect of ferulic acid on LPS-induced septic mice, results showed that ferulic acid significantly improved the survival rate and reduced the serum concentrations of IL-1β and TNF-α MedComm (2020). 2023 Apr 20;4(3):e255.
Mice High-fat diet model Dietary supplementation 50 mg/kg 8 weeks To investigate the effect of FA on gut health in mice fed a high-fat diet, results showed that FA reduced lymphocyte infiltration and protected the intestinal epithelial barrier. Antioxidants (Basel). 2022 Jul 26;11(8):1448.
APP/PS1 mice Alzheimer's disease model Drinking water 20 mg/kg Once daily for 30 days Ferulic acid counteracts ET1-mediated vasoconstriction, prevents reductions in density and diameter of hippocampal capillaries, and ameliorates Aβ plaque deposition and spatial memory deficits Neurotherapeutics. 2021 Apr;18(2):1064-1080
APP/PS1 Mice Alzheimer's Disease Model Oral 50 mg/kg Once daily for 4 months Long-term FA treatment improved behavioral and cognitive functions, reduced Aβ burden, and improved synaptic plasticity in APP/PS1 mice Neurotherapeutics. 2023 Jul;20(4):1081-1108.
C57BL/6J mice Oxygen-induced retinopathy (OIR) model Intragastric administration 50 mg/kg Twice daily for 5 days (P12 to P17) To evaluate the inhibitory effect of Ferulic Acid on retinal neovascularization in the OIR model, the results showed that Ferulic Acid significantly reduced the area of retinal neovascular clusters and the number of endothelial cells, and promoted reparative angiogenesis. Front Immunol. 2022 Sep 2;13:976729.
C57BL/J male mice LPS-induced tracheal injury model Intraperitoneally 100 mg/kg 12 hours before and 12 hours after intratracheal administration of LPS To evaluate the protective effect of Ferulic Acid on LPS-induced tracheal injury, results showed that Ferulic Acid significantly attenuated tracheal injury and restored the structure of tracheal epithelial cells and ENaC expression. Respir Res. 2021 Dec 4;22(1):308.

Ferulic Acid/阿魏酸 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03092076 Healthy Phase 1 Completed - -
NCT01982734 Pharmacokinetics of New Curcum... 展开 >>in Formulations Safety of New Curcumin Formulations 收起 << Early Phase 1 Completed - Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 <<
NCT02944084 Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake 收起 << Early Phase 1 Completed - Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 <<

Ferulic Acid/阿魏酸 参考文献

[1]Park HJ, Cho JH, et al. Whitening and anti-wrinkle activities of ferulic acid isolated from Tetragonia tetragonioides in B16F10 melanoma and CCD-986sk fibroblast cells. J Nat Med. 2018;72(1):127-135.

[2]Sudhagar S, Sathya S, et al. Inhibition of epidermal growth factor receptor by ferulic acid and 4-vinylguaiacol in human breast cancer cells. Biotechnol Lett. 2018;40(2):257-262.

[3]Wang H, Sun X, et al. Ferulic acid attenuates diabetes-induced cognitive impairment in rats via regulation of PTP1B and insulin signaling pathway. Physiol Behav. 2017.

[4]Liu YM, Shen JD, et al. Ferulic acid inhibits neuro-inflammation in mice exposed to chronic unpredictable mild stress. Int Immunopharmacol. 2017.

Ferulic Acid/阿魏酸 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.15mL

1.03mL

0.52mL

25.75mL

5.15mL

2.57mL

51.50mL

10.30mL

5.15mL

Ferulic Acid/阿魏酸 技术信息

CAS号1135-24-6
分子式C10H10O4
分子量 194.18
SMILES Code C1=C(C=CC(O)=O)C=CC(=C1OC)O
MDL No. MFCD00004400
别名 3-甲氧基-4-羟基苯基丙烯酸 ;Coniferic acid; 4-hydroxy-3-Methoxycinnamic Acid; Ferulic Acid, Methyl ferulate, trans-Ferulic acid, Coniferic acid, NSC 2821, NSC2821, NSC-2821; NSC 674320; NSC 51986; NSC 2821; Fumalic Acid
运输蓝冰
InChI Key KSEBMYQBYZTDHS-HWKANZROSA-N
Pubchem ID 445858
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 105 mg/mL(540.72 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。